Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. TOT BIOPHARM International Company Limited
  6. News
  7. Summary
    1875   HK0000545266

TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

(1875)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
01/12TOT Biopharm International Unit Grants Kexing License to Commercialize Cancer Drug Over..
MT
01/03TOT Biopharm Arm Engages MCC Unit to Construct Global R&D Center in Chinese Province
MT
2021TOT Biopharm Sells 1 Million Shares in Lumosa Therapeutics to Center Laboratories
MT
2021TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin« (TAB008, Bevacizum..
PR
2021TOT BIOPHARM International Company Limited Announces NMPA Granted Marketing Approval fo..
CI
2021TOT Biopharm's Lung Cance Drug Bags Marketing Approval in China; Shares Rally 5%
MT
2021TOT Biopharm International Forms Pharma Sales JV With China Resources Pharmaceutical
MT
2021TOT Biopharm Narrows Loss in January-September as Revenue Doubles; Shares Rally 4%
MT
2021TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Resu..
CI
2021TOT BIOPHARM INTERNATIONAL : 2021 Interim Revenue Surges 78% to RMB23.13 million
AQ
2021TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Resu..
CI
2021TOT BIOPHARM INTERNATIONAL : Cancer Drug Wins Registration, Marketing Approvals in China; ..
MT
2021Tot Biopharm International Company Limited Announces Drug Registration Approval for Tem..
CI
2021TOT BIOPHARM INTERNATIONAL : Wins Approval to Sell Appetite Stimulant in China
MT
2021TOT BIOPHARM INTERNATIONAL : Voluntary announcement - marketing approval for megestrol ace..
PU
More most relevant news
All news about TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
01/12TOT Biopharm International Unit Grants Kexing License to Commercialize Cancer Drug Over..
MT
01/03TOT Biopharm Arm Engages MCC Unit to Construct Global R&D Center in Chinese Province
MT
2021TOT Biopharm Sells 1 Million Shares in Lumosa Therapeutics to Center Laboratories
MT
2021TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin« (TAB008, Bevacizum..
PR
2021TOT BIOPHARM International Company Limited Announces NMPA Granted Marketing Approval fo..
CI
2021TOT Biopharm's Lung Cance Drug Bags Marketing Approval in China; Shares Rally 5%
MT
2021TOT Biopharm International Forms Pharma Sales JV With China Resources Pharmaceutical
MT
2021TOT Biopharm Narrows Loss in January-September as Revenue Doubles; Shares Rally 4%
MT
2021TOT BIOPHARM International Company Limited Reports Unaudited Consolidated Earnings Resu..
CI
2021TOT BIOPHARM INTERNATIONAL : 2021 Interim Revenue Surges 78% to RMB23.13 million
AQ
More news
News in other languages on TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
2021TOT Biopharm réduit sa perte en janvier-septembre et double ses revenus ; les actions a..
2021Le médicament contre le cancer de TOT Biopharm obtient l'enregistrement et l'autorisati..
2021TOT Biopharm réduit sa perte au premier trimestre
2021TOT Biopharm réduit sa perte en 2020 en raison de la baisse des dépenses ; les actions ..
2021TOT Biopharm obtient le feu vert de la FDA pour un essai de phase III sur un médicament..
More news
Press releases
2021TOT BIOPHARM Announces NMPA Granted Marketing Approval for Pusintin« (TAB008, Bevacizum..
PR
2021TOT BIOPHARM INTERNATIONAL : 2021 Interim Revenue Surges 78% to RMB23.13 million
AQ
2021TOT BIOPHARM INTERNATIONAL : Voluntary announcement - marketing approval for megestrol ace..
PU
2021TOT BIOPHARM INTERNATIONAL : Certain unaudited financial information for the three months ..
PU
2021TOT BIOPHARM INTERNATIONAL : Announces A Number of Key Anti-Tumor Drugs Have Entered the P..
AQ
More press releases
Upcoming event on TOT BIOPHARM INTERNATIONAL COMPANY LIMITED